Connection

Taixing Cui to Angiotensin II Type 1 Receptor Blockers

This is a "connection" page, showing publications Taixing Cui has written about Angiotensin II Type 1 Receptor Blockers.
  1. Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension. 2004 Nov; 44(5):758-63.
    View in: PubMed
    Score: 0.056
  2. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice. Hypertension. 2004 May; 43(5):1003-10.
    View in: PubMed
    Score: 0.054
  3. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan. Hypertension. 2004 Feb; 43(2):263-9.
    View in: PubMed
    Score: 0.053
  4. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells. Mol Endocrinol. 2004 Mar; 18(3):666-78.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.